The profile of T-cells (CD4 +, CD8 +) and natural killer cells (CD16 / 56+) in STEMI patients with poor prognosis

13 March 2021 (08:30 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Biomarkers ACVC Premium Access ACVC 2021